Medications ›imatinib mesylate

imatinib mesylate

RxCUI 284924 precise ingredient

Contraindicated with · 6

Diagnoses3

Pregnancy Reproduction Drug Hypersensitivity

Condition families3

Reproductive Physiological Phenomena Drug-Related Side Effects and Adverse Reactions Chemically-Induced Disorders

Indicated for · 41

Diagnoses20

Blast Crisis Carcinogenesis Cell Transformation, Neoplastic Dermatofibrosarcoma Fibrosarcoma Mastocytosis, Systemic Mastocytosis Neoplasms, Fibrous Tissue Leukemia, Myeloid, Accelerated Phase Eosinophilia Hypereosinophilic Syndrome Leukemia, Myelogenous, Chronic, BCR-ABL Positive Neoplasms, Connective Tissue Sarcoma Leukemia, Lymphoid Leukemia, Myeloid Neoplasms, Connective and Soft Tissue Leukemia Chronic Disease Disease Attributes

Condition families21

Myelodysplastic-Myeloproliferative Diseases Mast Cell Activation Disorders Neoplastic Processes Myeloproliferative Disorders Leukocyte Disorders Gastrointestinal Neoplasms Bone Marrow Diseases Digestive System Neoplasms Lymphatic Diseases Immunoproliferative Disorders Lymphoproliferative Disorders Neoplasms by Histologic Type Neoplasms by Site Gastrointestinal Diseases Hematologic Diseases Hemic and Lymphatic Diseases Neoplasms Digestive System Diseases Pathologic Processes Immune System Diseases Pathological Conditions, Signs and Symptoms

MED-RT, published by the VA through NLM. Relationships attach at the ingredient level, not to a specific product or dose.

RADV audits Coding jobs Chart counter Hours & decimal time About Contact Help Terms Privacy

Innova Coding Suite extension — both tools in your browser: Add to Chrome · Add to Edge

InnovaRx — Innova Health Strategies. ICD-10-CM and the CMS-HCC risk adjustment models are published by CMS and NCHS and are in the public domain. Effective date 2026-10-22 travels in the URL, so this link shows anyone exactly what you see.